Who invested in Allotera Therapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$150Mraised across 2 rounds since 2025, from 3 sources

$115MSeries C$35MSeries C

Latest round: Series C, $35MJul 2026
Biggest round: $115MSeries C · Aug 2025
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$115MSeries C$35MSeries C

First round: Series C, $115M
Biggest round: $115M
Between rounds: 11 months

The rounds

Jul 2026
Series C$35M3 new2 returning
Reported by Firms' own news pages and 1 otherSEC filing: $123M sold
Aug 2025
Series C$115M3 new
Source recorded

Founders and team

From Allotera Therapeutics's own website: 2 on the team.

Ghee KimVP, CMC Operations
Jacqui BlemVP, Clinical Operations

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2025Series C2026

Sands Capital Ventures

Alpha Wave GlobalFidelity

BioGenerator

Lightchain CapitalBlood Cancer United's Therapy Acceleration Program (TAP)

Everyone who backed them

Sands Capital VenturesPrivate equity2rounds

Alpha Wave GlobalPrivate equity2rounds

FidelityVC firm1round

BioGeneratorVenture studio1round

Lightchain CapitalVC firm1round

Blood Cancer United's Therapy Acceleration Program (TAP)Growth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Allotera Therapeutics

Who invested in Allotera Therapeutics?

Allotera Therapeutics's investors include Sands Capital Ventures, Alpha Wave Global, Fidelity, BioGenerator and Lightchain Capital, and 1 more on record.